Taking a Deep Dive Into Three-year Data on Lebrikizumab in AD With Raj Chovatiya, MD, PhD March 7, 2025
Survey: Chronic Hand Eczema Is Widely Misunderstood and Inadequately Managed by Many Derms March 5, 2025
Apogee Pipeline Update: Positive Interim Phase 1 Results From the APG990 Healthy Volunteer Trial Unlock Potential Maintenance Dosing Every Three and Six Months for APG279 (APG777 + APG990) March 3, 2025
U.S. FDA Accepts sNDA for Arcutis’ Roflumilast Cream 0.05% (Zoryve) for Children Aged 2 to 5 with Mild-to-moderate AD; PDUFA Date Set February 26, 2025